Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.
10.1007/s12264-018-0230-x
- Author:
Chaohua PENG
1
;
Gaochun ZHU
1
;
Xiangqian LIU
2
;
He LI
3
Author Information
1. Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
2. Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. liu_xiangqian@hotmail.com.
3. Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. heli@mails.tjmu.edu.cn.
- Publication Type:Journal Article
- Keywords:
Basal ganglia;
Hippocampus;
Huntington’s disease;
Synaptic vesicle protein 2C
- MeSH:
Aging;
metabolism;
Animals;
Brain;
metabolism;
pathology;
Cell Line, Tumor;
Gene Expression;
physiology;
Huntingtin Protein;
genetics;
metabolism;
Membrane Glycoproteins;
metabolism;
Mice;
Mice, Transgenic;
Mutation;
Nerve Tissue Proteins;
metabolism;
RNA, Messenger;
metabolism;
Transcription, Genetic;
physiology
- From:Neuroscience Bulletin
2018;34(5):747-758
- CountryChina
- Language:English
-
Abstract:
Huntington's disease (HD) is a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin (Htt) protein. Mutant Htt causes synaptic transmission dysfunctions by interfering in the expression of synaptic proteins, leading to early HD symptoms. Synaptic vesicle proteins 2 (SV2s), a family of synaptic vesicle proteins including 3 members, SV2A, SV2B, and SV2C, plays important roles in synaptic physiology. Here, we investigated whether the expression of SV2s is affected by mutant Htt in the brains of HD transgenic (TG) mice and Neuro2a mouse neuroblastoma cells (N2a cells) expressing mutant Htt. Western blot analysis showed that the protein levels of SV2A and SV2B were not significantly changed in the brains of HD TG mice expressing mutant Htt with 82 glutamine repeats. However, in the TG mouse brain there was a dramatic decrease in the protein level of SV2C, which has a restricted distribution pattern in regions particularly vulnerable in HD. Immunostaining revealed that the immunoreactivity of SV2C was progressively weakened in the basal ganglia and hippocampus of TG mice. RT-PCR demonstrated that the mRNA level of SV2C progressively declined in the TG mouse brain without detectable changes in the mRNA levels of SV2A and SV2B, indicating that mutant Htt selectively inhibits the transcriptional expression of SV2C. Furthermore, we found that only SV2C expression was progressively inhibited in N2a cells expressing a mutant Htt containing 120 glutamine repeats. These findings suggest that the synaptic dysfunction in HD results from the mutant Htt-mediated inhibition of SV2C transcriptional expression. These data also imply that the restricted distribution and decreased expression of SV2C contribute to the brain region-selective pathology of HD.
